An Update on Treatments for Lichen Planopilaris
Abstract
Lichen planopilaris (LPP) is an immune-mediated cicatricial alopecia that is often challenging to treat. In LPP, hair follicles are selectively destroyed by a chronic lymphocytic inflammatory process, leading to irreversible scarring and permanent hair loss. Several variants of LPP have been described in the literature including the classic form, the Graham-Little-Piccardi-Lassueur syndrome, frontal fibrosing alopecia, and recently, a new clinical variant, lichen planopilaris diffuse pattern.
References
Goldstein AT, Marinoff SC, Christopher K, Srodon M. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med. 2005;50(7):477-480.
Bleeker MC, Visser PJ, Overbeek LI, van Beurden M, Berkhof J. Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma. Cancer Epidemiol Biomarkers Prev. 2016;25(8):1224-1230. doi:10.1158/1055-9965.EPI-16-0019.
Fistarol SK, Itin PH. Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol. 2013;14(1):27-47. doi:10.1007/s40257-012-0006-4.
Gao XH, Barnardo MC, Winsey S, et al. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus. J Invest Dermatol. 2005;125(5):895-899. doi:10.1111/j.0022-202X.2005.23905.x.
Marren P, Yell J, Charnock FM, Bunce M, Welsh K, Wojnarowska F. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol. 1995;132(2):197-203. doi:10.1111/j.1365-2133.1995.tb05013.x.
Powell J, Wojnarowska F, Winsey S, Marren P, Welsh K. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol. 2000;142(3):481-484. doi:10.1046/j.1365-2133.2000.03360.x.
Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity–a study of 350 women. Br J Dermatol. 1988 Jan;118(1):41-6. doi: 10.1111/j.1365-2133.1988.tb01748.x. Erratum in: Br J Dermatol 1988 May;118(5):736. PMID: 3342175.
Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol. 2008 Nov;144(11):1432-5. doi: 10.1001/archderm.144.11.1432. PMID: 19015417.
Eisendle K, Grabner T, Kutzner H, Zelger B. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus. Arch Dermatol. 2008;144(5):591-598. doi:10.1001/archderm.144.5.591.
Requena López S, Hidalgo García Y, Gómez Díez S, Vivanco Allende B. Morphea and Extragenital Lichen Sclerosus et Atrophicus After Influenza Vaccination. Morfea y liquen escleroatrófico extragenital generalizados tras vacuna antigripal. Actas Dermosifiliogr. 2018;109(1):86-88. doi:10.1016/j.ad.2017.05.016.
Pass CJ. An unusual variant of lichen sclerosus et atrophicus: delayed appearance in a surgical scar. Cutis. 1984;33(4):405-408.
De Giorgi V, Scarfì F, Silvestri F, et al. Genital piercing: A warning for the risk of vulvar lichen sclerosus. Dermatol Ther. 2021;34(1):e14703. doi:10.1111/dth.14703.
Fergus KB, Lee AW, Baradaran N, et al. Pathophysiology, Clinical Manifestations, and Treatment of Lichen Sclerosus: A Systematic Review. Urology. 2020;135:11-19. doi:10.1016/j.urology.2019.09.034.
Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4th edition. Elsevier; 2018.
Patterson J. Weedon’s Skin Pathology. 4th Edition. Elsevier; 2014.
Rapini R. Practical Dermatopathology. Elsevier, 2012.
Kirtschig G, Becker K, Günthert A, et al. Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. J Eur Acad Dermatol Venereol. 2015;29(10):e1-e43. doi:10.1111/jdv.13136.
Kim GW, Park HJ, Kim HS, et al. Topical tacrolimus ointment for the treatment of lichen sclerosus, comparing genital and extragenital involvement. J Dermatol. 2012;39(2):145-150. doi:10.1111/j.1346-8138.2011.01384.x.
Cattaneo A, Carli P, De Marco A, et al. Testosterone maintenance therapy. Effects on vulvar lichen sclerosus treated with clobetasol propionate. J Reprod Med. 1996;41(2):99-102.
Bornstein J, Heifetz S, Kellner Y, Stolar Z, Abramovici H. Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus. Am J Obstet Gynecol. 1998;178(1 Pt 1):80-84. doi:10.1016/s0002-9378(98)70631-3.
Cuellar-Barboza A, Bashyam AM, Ghamrawi RI, Aickara D, Feldman SR, Pichardo RO. Methotrexate for the treatment of recalcitrant genital and extragenital lichen sclerosus: A retrospective series. Dermatol Ther. 2020;33(4):e13473. doi:10.1111/dth.13473.
Bousema MT, Romppanen U, Geiger JM, et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol. 1994;30(2 Pt 1):225-231. doi:10.1016/s0190-9622(94)70021-4.
Ioannides D, Lazaridou E, Apalla Z, Sotiriou E, Gregoriou S, Rigopoulos D. Acitretin for severe lichen sclerosus of male genitalia: a randomized, placebo controlled study. J Urol. 2010;183(4):1395-1399. doi:10.1016/j.juro.2009.12.057.
Shelley WB, Shelley ED, Amurao CV. Treatment of lichen sclerosus with antibiotics. Int J Dermatol. 2006;45(9):1104-1106. doi:10.1111/j.1365-4632.2006.02978.x.
Gardner AN, Aschkenazi SO. The short-term efficacy and safety of fractional CO2 laser therapy for vulvovaginal symptoms in menopause, breast cancer, and lichen sclerosus [published online ahead of print, 2021 Jan 4]. Menopause. 2021;Publish Ahead of Print:10.1097/GME.0000000000001727. doi:10.1097/GME.0000000000001727.
Mendieta-Eckert M, Torrontegui Bilbao J, Zabalza Estévez I, Landa Gundin N. Treatment of Vulvar Lichen Sclerosus et Atrophicus With Fractional Carbon Dioxide Laser Therapy: A Report of 4 Cases. Tratamiento de liquen escleroso y atrófico vulvar con láser de dióxido de carbono fraccionado. Presentación de cuatro casos. Actas Dermosifiliogr. 2021;112(1):85-88. doi:10.1016/j.ad.2019.03.021.
Mendieta-Eckert M, Ocerin-Guerra I, Landa-Gundin N. Lichen sclerosus et atrophicus in a surgical scar treated with fractional laser. J Cosmet Laser Ther. 2017;19(2):106-108. doi:10.1080/14764172.2016.1262955.
Lee A, Lim A, Fischer G. Fractional carbon dioxide laser in recalcitrant vulval lichen sclerosus. Australas J Dermatol. 2016;57(1):39-43. doi:10.1111/ajd.12305.
Pagano T, et al. “Effect of rescue fractional microablative CO2 laser on symptoms and sexual dysfunction in women affected by vulvar lichen sclerosus resistant to long-term use of topic corticosteroid: a prospective longitudinal study.” Menopause. 2020 Apr;27(4):418-422.
Ferrara F, Messori S, Abbenante D, Patrizi A, Bardazzi F. Fractional CO2 laser therapy of lichen sclerosus in males: a new therapeutic opportunity? [published online ahead of print, 2020 Jul 20]. J Dermatolog Treat. 2020;1-5. doi:10.1080/09546634.2020.1793886.
Tedesco M, Pranteda G, Chichierchia G, et al. The use of PRP (platelet-rich plasma) in patients affected by genital lichen sclerosus: clinical analysis and results. J Eur Acad Dermatol Venereol. 2019;33(2):e58-e59. doi:10.1111/jdv.15190.
Behnia-Willison F, Pour NR, Mohamadi B, et al. Use of Platelet-rich Plasma for Vulvovaginal Autoimmune Conditions Like Lichen Sclerosus. Plast Reconstr Surg Glob Open. 2016;4(11):e1124. Published 2016 Nov 23. doi:10.1097/GOX.0000000000001124.
Casabona F, Gambelli I, Casabona F, Santi P, Santori G, Baldelli I. Autologous platelet-rich plasma (PRP) in chronic penile lichen sclerosus: the impact on tissue repair and patient quality of life. Int Urol Nephrol. 2017;49(4):573-580. doi:10.1007/s11255-017-1523-0.
Navarrete J, Echarte L, Sujanov A, et al. Platelet-rich plasma for male genital lichen sclerosus resistant to conventional therapy: First prospective study. Dermatol Ther. 2020;33(6):e14032. doi:10.1111/dth.14032.
Tedesco M, Garelli V, Bellei B, et al. Platelet-rich plasma for genital lichen sclerosus: analysis and results of 94 patients. Are there gender-related differences in symptoms and therapeutic response to PRP? [published online ahead of print, 2020 Dec 6]. J Dermatolog Treat. 2020;1-5. doi:10.1080/09546634.2020.1854650.
